investorscraft@gmail.com

Intrinsic Value of ChemoCentryx, Inc. (CCXI)

Previous Close$0.00
Intrinsic Value
Upside potential
Previous Close
$0.00
* Our model cannot be used “out of the box” for the valuation of this stock. You can still do your own valuation by changing the valuation input parameters.

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2021-12-31 and quarterly data as of 2022-06-30.

  1. Annual
  2. Quarterly YoY
  3. Quarterly QoQ

Annual revenue growth rates, % (past and forecasted)

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year(a)2022202320242025202620272028202920302031203220332034203520362037203820392040204120422043204420452046

INCOME STATEMENT

Revenue growth rate, %-50.3NaN
Revenue, $32NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $m162NaN
Operating income, $m-130NaN
EBITDA, $m-127NaN
Interest expense (income), $mNaN
Earnings before tax, $m-132NaN
Tax expense, $m0NaN
Net income, $m-132NaN

BALANCE SHEET

Cash and short-term investments, $m264NaN
Total assets, $m426NaN
Adjusted assets (=assets-cash), $m161NaN
Average production assets, $m397NaN
Working capital, $m206NaN
Total debt, $m24NaN
Total liabilities, $m140NaN
Total equity, $m286NaN
Debt-to-equity ratio0.083NaN
Adjusted equity ratio0.252NaN

CASH FLOW

Net income, $m-132NaN
Depreciation, amort., depletion, $m3NaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $m-76NaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $m-19NaN
Free cash flow, $m-57NaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $m206
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount